openPR Logo
Press release

Maryland Medicare Options Announces Major Expansion For Advantage Plan Clients

09-08-2025 06:12 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Maryland Medicare Options is a Medicare-focused insurance agency based in Annapolis, MD.

Maryland Medicare Options is a Medicare-focused insurance agency based in Annapolis, MD.

Maryland Medicare Options, a Senior Health Insurance agency in Annapolis, MD. has recently announced a major expansion and name change to better serve their clients. With massive changes in Medicare Advantage Plans throughout Maryland, the agency felt the need to add additional insurance Brokers to expand their ability to help their client base. Founder and CEO, Peter Palmiotto, announced the company's addition of two new Broker agents and a redesigned website as well as company structure.
One of Maryland's premier Medicare insurance agency, Maryland Medicare Options [https://marylandmedicareoptions.com/], has announced their expansion and new company name amidst a dynamic Annual Enrollment season for 2026 Advantage Plans.

Found and CEO, Peter Palmiotto, explained "With the increased demand for our services, I felt it was critical that we expand our capcity to serve our clients. We've added two additional independent Medicare Brokers who work directly with me handling more of the day-to-day sales and customer support." Palmiotto, a Medicare Broker himself since 2011, further stated "We also felt the need to broaden our appeal with a new website and new corporate branding. We're happy to be launching East Coast Health Advisors, which will serve as our hub to develop not only our in-house sales team, but will handle recruiting and training of our sub-agents as we grow into a full-service Agency. Our long term goal is to offer our services to clients throughout the Mid-Atlantic region."

Mutiple nationwide Maryland Medicare Advantage Plans [https://marylandmedicareoptions.com/] have announced their reduction or total exit from the State of Maryland affecting nearly 100,000 seniors in 2026. This represents almost 50% of all Medicare Advantage Plan users in Maryland, with plans termiating at the end of 2025. "While we don't like seeing people lose coverage, this presents a major opportunity for us to pick up a large portion of this business," said Palmiotto, further adding "We now have a much greater capbility to handle the call volume and enroll seniors in a new Advantage Plan for 2026."

While Maryand Medicare Options (MMO) was founded in 2020, it has served the local region well, enrolling more than 1,300 clients in just a few short years. Palmiotto clarified that the original brand isn't going anywhere, and will continue to be used for marketing in the local Maryland market. Clients should expect to see a combination of marketing from both Maryland Medicare Options and the newly launched East Coast Health Advisors for a few months into 2026, while they sunset marketing items from MMO over Q1 of 2026.

"We feel we're well positioned for fast growth throughout 2026 and are excited to improve our overall customer service. We're streamlining our service to our seniors, which I'm sure they'll appreciate," Palmiotto explained.

Both entities are now under one roof and can be reached at (410)896-1212 for all Medicare insurance inquiries.

Media Contact
Company Name: Maryland Medicare Options
Contact Person: Peter Palmiotto
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=maryland-medicare-options-announces-major-expansion-for-advantage-plan-clients]
Phone: 410-896-1212
Address:619 Ridgely Ave
City: Annapolis
State: MD
Country: United States
Website: https://marylandmedicareoptions.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Maryland Medicare Options Announces Major Expansion For Advantage Plan Clients here

News-ID: 4174274 • Views:

More Releases from ABNewswire

ESR1 mutated metastatic breast cancer Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
ESR1 mutated metastatic breast cancer Market Analysis 2034 - Competitive Landsca …
The ESR1-mutated metastatic breast cancer companies are AstraZeneca, Olema Pharmaceuticals, Arvinas, Sermonix Pharmaceuticals, Roche, Eli Lilly and Company, H3 Biomedicine, Eisai, Pfizer, Sun Pharma Advanced Research Company, Zenopharm, Daiichi Sankyo, and others. ESR1-mutated metastatic breast cancer market, valued at approximately USD 1.3 billion in 2023, is projected to experience substantial growth during the forecast period (2024-2034). Furthermore, the US accounts for the largest market share, representing approximately 63% of the total
Psychosis in Parkinson's and Alzheimer's Disease Market Analysis 2034 - Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight
Psychosis in Parkinson's and Alzheimer's Disease Market Analysis 2034 - Competit …
Key Psychosis in Parkinson's and Alzheimer's Disease companies actively developing therapies in this space include Karuna Therapeutics, Sunovion Pharmaceuticals, Intra-Cellular Therapies, Acadia Pharmaceuticals, and others. Promising pipeline candidates include NUPLAZID, Ulotaront, KarXT, ITI-1284, among others. DelveInsight has launched a new report on "Psychosis in Parkinson's and Alzheimer's Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Psychosis in Parkinson's and Alzheimer's Disease, historical and forecasted
Irritable Bowel Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight
Irritable Bowel Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
Irritable Bowel Syndrome companies working in the treatment market are P4 Microbiome, Biomica, Invea Therapeutics, Inc., RaQualia Pharma, RedHill Biopharma Ltd., 4D pharma, SV-MMX Cosmo Pharmaceuticals, and others. According to DelveInsight's assessment, the global Irritable Bowel Syndrome (IBS) pipeline comprises 15+ Irritable Bowel Syndrome companies actively developing 20+ Irritable Bowel Syndrome treatment therapies. The report provides an in-depth analysis of clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and
Fuchs Endothelial Corneal Dystrophy Market Outlook 2024-2034: From Standard of Care to Novel Therapeutics
Fuchs Endothelial Corneal Dystrophy Market Outlook 2024-2034: From Standard of C …
The US accounts for the largest market size of Fuchs Endothelial Corneal Dystrophy in 2023, i.e. nearly USD 394 million, in comparison to EU4 (Germany, Italy, France, and Spain) and the UK, and Japan. In the 7MM, the market mainly consisted of Standard of care (Hyperosmotic sodium chloride, Steroids, etc.), which generated nearly USD 850 million in 2023. Fuchs Endothelial Corneal Dystrophy (FECD) is a progressive hereditary disease that affects the endothelial

All 5 Releases


More Releases for Medicare

Local Medicare Agents Expand Services to Support Fresno Residents with Medicare …
Image: https://www.globalnewslines.com/uploads/2025/02/1740481236.jpg Local Medicare Agents has announced an expansion of its Medicare support services exclusively for residents of Fresno. The agency, known for its education-driven approach, is committed to helping seniors and Medicare-eligible individuals navigate the complexities of Medicare with clarity and confidence. FRESNO, CA - September 8, 2025 - Local Medicare Agents [https://medicareu.com/locations/fresno/] has announced an expansion of its Medicare support services exclusively for residents of Fresno. The agency, known for
New 2025 Medicare Guide by Joshua David Medicare Aims to Prevent Enrollment Erro …
Image: https://www.globalnewslines.com/uploads/2025/04/dd3e1e3657c1272957ff8b316708cc30.jpg As Medicare enrollment approaches for millions turning 65 in 2025, a new publication from Joshua David Medicare offers essential guidance to help enrollees avoid costly mistakes. Titled Medicare Breakdown: The Alphabet Soup of Medicare , the guidebook by healthcare experts Francois Lodonou and Joshua David Shinn outlines the seven most common errors individuals make when entering the Medicare system. Among the most critical issues covered are enrollment timing, misunderstandings about
Local Medicare Agents - LMA Insurance Now Offers Medicare Insurance Broker Consu …
Image: https://www.globalnewslines.com/uploads/2025/01/1737380803.jpg Local Medicare Agents - LMA Insurance, a trusted name in healthcare coverage, is proud to announce its expanded services as a Medicare Insurance Broker in Fresno. Fresno, CA - Local Medicare Agents - LMA Insurance [https://medicareu.com/locations/fresno/medicare-insurance-broker/], a trusted name in healthcare coverage, is proud to announce its expanded services as a Medicare Insurance Broker in Fresno. With a commitment to education, personalized service, and empowering clients with the freedom of
Medicare Advantage Market
The "Medicare Advantage Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Medicare Advantage Market, 2024-2031 Verified Market Research's most recent report, "Medicare Advantage Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Medicare Advantage: Market 2022 Growing Popularity and Emerging Trends by Top Ke …
The technique applied to derive the market share of the Medicare Advantage Market 2022 built on the end-user sector and market area is bottom-up forecasting. The key sources of information consist of several Medicare Advantage industry professionals, suppliers, manufacturers, associations along with business distributions. The research report defines exclusive benefits of the various market size, shares, and the patent industry. The key aim of the Medicare Advantage research report is
Medicare Advantage: Market 2022 to Witness Astonishing Growth with Key Players | …
Qurate's most recent research report on Medicare Advantage was performed by extremely qualified research professionals and business experts in order to provide an in-depth assessment on the market. The study on Medicare Advantage is extensive and consist of over 120 pages. The research analysis on Medicare Advantage is the proper mix of qualitative and quantitative information with an emphasis on crucial characteristics of the Medicare Advantage. These involve - - Significant